Atossa Therapeutics
ATOS
ATOS
77 hedge funds and large institutions have $31.2M invested in Atossa Therapeutics in 2024 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 21 increasing their positions, 14 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
5.46% more ownership
Funds ownership: 15.39% → 20.85% (+5.5%)
10% less capital invested
Capital invested by funds: $34.7M → $31.2M (-$3.55M)
Holders
77
Holding in Top 10
–
Calls
$765K
Puts
$103K
Top Buyers
| 1 | +$7.67M | |
| 2 | +$1.85M | |
| 3 | +$1.39M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$871K |
| 5 |
Bank of New York Mellon
New York
|
+$475K |
Top Sellers
| 1 | -$4.01M | |
| 2 | -$1.19M | |
| 3 | -$626K | |
| 4 |
HF
HRT Financial
New York
|
-$524K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$490K |